ELAN Elanco Animal Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ELAN

Price (delayed)

$24.725

Market cap

$12.35B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.5

Enterprise value

$16.22B

?
Relative Growth: Rel. Growth: 30
Relative Strength: Rel. Strength: 75
Relative Valuation: Rel. Valuation: 27
Relative Profitability: Rel. Profitability: 32

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, ...

Highlights
Elanco Animal Health's revenue has increased by 11% YoY and by 3.8% from the previous quarter
The gross profit has grown by 11% YoY and by 3.9% from the previous quarter
The quick ratio has contracted by 22% YoY but it has grown by 2.2% from the previous quarter
The company's EPS has shrunk by 166% YoY and by 6% QoQ
Elanco Animal Health's net income has plunged by 165% YoY and by 4.3% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Peers: OPK ORGO

Key stats

What are the main financial stats of ELAN

ELAN stock price

How has the Elanco Animal Health stock price performed over time
Intraday
0.63%
1 week
3.11%
1 month
9.84%
1 year
83.97%
YTD
9.26%
QTD
3.32%

Financial performance

How have Elanco Animal Health's revenue and profit performed over time
Revenue
$4.89B
Gross profit
$2.69B
Operating income
$56M
Net income
-$242M
Gross margin
55.1%
Net margin
-4.9%
Elanco Animal Health's net income has plunged by 165% YoY and by 4.3% from the previous quarter
The net margin has dropped by 158% year-on-year
The company's operating margin has shrunk by 61% YoY
Elanco Animal Health's operating income has plunged by 56% YoY

Price vs fundamentals

How does ELAN's price correlate with its fundamentals

Growth

What is Elanco Animal Health's growth rate over time

Valuation

What is Elanco Animal Health stock price valuation
ELAN P/E details
P/E
N/A
P/B
1.89
P/S
2.51
EV/EBIT
405.52
EV/EBITDA
22.19
EV/Sales
3.32
The company's EPS has shrunk by 166% YoY and by 6% QoQ
The price to book (P/B) is 45% higher than the 5-year quarterly average of 1.3 and 25% higher than the last 4 quarters average of 1.5
ELAN's equity is up by 2.3% YoY
ELAN's P/S is 32% above its 5-year quarterly average of 1.9 and 19% above its last 4 quarters average of 2.1
Elanco Animal Health's revenue has increased by 11% YoY and by 3.8% from the previous quarter

Efficiency

How efficient is Elanco Animal Health business performance
The company's return on assets has shrunk by 164% YoY and by 6% QoQ
Elanco Animal Health's ROE has plunged by 160% YoY and by 2.9% from the previous quarter
Elanco Animal Health's ROIC has plunged by 95% YoY
The company's return on sales has shrunk by 95% YoY

Dividends

What is ELAN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELAN.

Financial health

How did Elanco Animal Health financials performed over time
Elanco Animal Health's total assets is 97% higher than its total liabilities
The quick ratio has contracted by 22% YoY but it has grown by 2.2% from the previous quarter
Elanco Animal Health's current ratio has decreased by 20% YoY
The debt is 34% smaller than the equity
The debt to equity has declined by 4.3% year-on-year
The debt is down by 2.2% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.